We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Precision Medicine Institute
Colleague Insights
Video Expert Opinion
Resource Library
Conferences
Tumor Boards
Sign in
Join now
featured
Published in Lung Cancer

Expert Opinion / Cases · December 03, 2021

Isolated CNS Recurrence After Definitive Therapy for Stage III NSCLC

Written by
Michael J. Grant MD

 

 Save  Recommend
 Share

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • marco buso

    Dec 10, 2021

    Whole brain radiotherapy
No systemic therapy, surveillance imaging

  • Leoncio Arribas Alpuente

    Dec 10, 2021

    WBRT plus concomitant boost, without systemic therapy if only had brain metastasis

  • Jean-Yves Douillard

    Feb 11, 2022

    This case should be discussed in MDT with a radiation oncologist. 
The patient is 75, he has brain metastasis as a single organ site. Based on the number of metastatic lesions, I would favour Whole Brain Radiotherapy. After re-evaluation of the brain and in the absence of disease progression at other sites, in a discussion with the patient, I would suggest no further systemic therapy, surveillance imaging and would wait for documented relapse to start another treatment depending on the clinical presentation.

  • Jul 06, 2022

    Pending Moderator approval.
    Delete

Further Reading

Most Read This Week

Recently Updated